{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:11:41Z","timestamp":1789582301960,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK62813"],"award-info":[{"award-number":["DK62813"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26640114"],"award-info":[{"award-number":["26640114"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H02657"],"award-info":[{"award-number":["15H02657"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16H05191"],"award-info":[{"award-number":["16H05191"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s10120-018-0844-8","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T12:28:46Z","timestamp":1529670526000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area"],"prefix":"10.1007","volume":"22","author":[{"given":"Boldbaatar","family":"Gantuya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khasag","family":"Oyuntsetseg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashdorj","family":"Bolor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansan","family":"Erdene-Ochir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruvjir","family":"Sanduijav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duger","family":"Davaadorj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tegshee","family":"Tserentogtokh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"844_CR1","unstructured":"http:\/\/globocan.iarc.fr\/\n                    \n                  . GLOBOCAN 2012 (IARC). Accessed 1 Jan 2018."},{"issue":"3","key":"844_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/00004836-199106000-00006","volume":"13","author":"ME Craanen","year":"1991","unstructured":"Craanen ME, Dekker W, Ferwerda J, Blok P, Tytgat GN. Early gastric cancer: a clinicopathologic study. J Clin Gastroenterol. 1991;13(3):274\u201383.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"844_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.41.2.142","volume":"41","author":"S Everett","year":"1997","unstructured":"Everett S, Axon A. Early gastric cancer in Europe. Gut. 1997;41(2):142\u201350.","journal-title":"Gut"},{"issue":"6","key":"844_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3904\/kjim.2015.30.6.747","volume":"30","author":"GH Kim","year":"2015","unstructured":"Kim GH, Bang SJ, Ende AR, Hwang JH. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans? Korean J Intern Med. 2015;30(6):747.","journal-title":"Korean J Intern Med"},{"issue":"957","key":"844_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/pgmj.2004.029330","volume":"81","author":"M Inoue","year":"2005","unstructured":"Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J. 2005;81(957):419\u201324.","journal-title":"Postgrad Med J"},{"issue":"6","key":"844_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5946\/ce.2014.47.6.497","volume":"47","author":"IJ Choi","year":"2014","unstructured":"Choi IJ. Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014;47(6):497\u2013503.","journal-title":"Clin Endosc"},{"issue":"4","key":"844_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jjco\/hyn017","volume":"38","author":"C Hamashima","year":"2008","unstructured":"Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38(4):259\u201367.","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"844_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.5946\/ce.2014.47.6.478","volume":"47","author":"JY Park","year":"2014","unstructured":"Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective. Clin Endosc. 2014;47(6):478\u201389.","journal-title":"Clin Endosc"},{"issue":"9","key":"844_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1080\/00365520802085395","volume":"43","author":"O Hosokawa","year":"2008","unstructured":"Hosokawa O, Miyanaga T, Kaizaki Y, Hattori M, Dohden K, Ohta K, et al. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol. 2008;43(9):1112\u20135.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"844_CR10","doi-asserted-by":"publisher","first-page":"e79088","DOI":"10.1371\/journal.pone.0079088","volume":"8","author":"C Hamashima","year":"2013","unstructured":"Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case\u2013control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One. 2013;8(11):e79088.","journal-title":"PLoS One"},{"issue":"38","key":"844_CR11","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.3748\/wjg.v20.i38.13842","volume":"20","author":"V Pasechnikov","year":"2014","unstructured":"Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20(38):13842\u201362.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"844_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1470-2045(08)70072-X","volume":"9","author":"WK Leung","year":"2008","unstructured":"Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279\u201387.","journal-title":"Lancet Oncol"},{"issue":"7","key":"844_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2183\/pjab.87.405","volume":"87","author":"K Miki","year":"2011","unstructured":"Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels\u2014\u201cABC method\u201d. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405\u201314.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"8","key":"844_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/00042737-200308000-00007","volume":"15","author":"EJ Kuipers","year":"2003","unstructured":"Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol. 2003;15(8):877\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"844_CR15","first-page":"S37","volume":"19","author":"P Correa","year":"1995","unstructured":"Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19(Suppl 1):S37\u201343.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"844_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10120-015-0473-4","volume":"19","author":"CH Park","year":"2016","unstructured":"Park CH, Kim EH, Jung DH, Chung H, Park JC, Shin SK, Lee SK, Lee YC. The new modified ABCD method for gastric neoplasm screening. Gastric Cancer. 2016;19(1):128\u201335.","journal-title":"Gastric Cancer."},{"issue":"11","key":"844_CR17","doi-asserted-by":"publisher","first-page":"e0142080","DOI":"10.1371\/journal.pone.0142080","volume":"10","author":"Y-K Huang","year":"2015","unstructured":"Huang Y-K, Yu J-C, Kang W-M, Ma Z-Q, Ye X, Tian S-B, et al. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis. PloS One. 2015;10(11):e0142080.","journal-title":"PloS One"},{"issue":"4","key":"844_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/1055-9965.EPI-07-2762","volume":"17","author":"K Yanaoka","year":"2008","unstructured":"Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, et al. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Prev Biomark. 2008;17(4):838\u201345.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"6","key":"844_CR19","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/ijc.28470","volume":"134","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134(6):1445\u201357.","journal-title":"Int J Cancer"},{"issue":"11","key":"844_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"844_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.gie.2013.04.167","volume":"78","author":"RN Sharaf","year":"2013","unstructured":"Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, Jain R, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216\u201324.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"844_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1349-7006.2007.00415.x","volume":"98","author":"T Uchida","year":"2007","unstructured":"Uchida T, Kanada R, Tsukamoto Y, Hijiya N, Matsuura K, Yano S, et al. Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci. 2007;98(4):521\u20138.","journal-title":"Cancer Sci"},{"issue":"10","key":"844_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161\u201381.","journal-title":"Am J Surg Pathol"},{"issue":"24","key":"844_CR24","first-page":"6735","volume":"52","author":"P Correa","year":"1992","unstructured":"Correa P. Human gastric carcinogenesis: a multistep and multifactorial process\u2014First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735\u201340.","journal-title":"Cancer Res"},{"issue":"3","key":"844_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2036.2004.02075.x","volume":"20","author":"G Nardone","year":"2004","unstructured":"Nardone G, Rocco A, Malfertheiner P. Review article: Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther. 2004;20(3):261\u201370.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"844_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bpg.2006.03.016","volume":"20","author":"M Vauhkonen","year":"2006","unstructured":"Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20(4):651\u201374.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"844_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1443-9573.2007.00278.x","volume":"8","author":"K Miki","year":"2007","unstructured":"Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8(1):8\u201314.","journal-title":"J Dig Dis"},{"issue":"1","key":"844_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00535-009-0142-7","volume":"45","author":"T Nakajima","year":"2010","unstructured":"Nakajima T, Enomoto S, Yamashita S, Ando T, Nakanishi Y, Nakazawa K, et al. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol. 2010;45(1):37\u201344.","journal-title":"J Gastroenterol"},{"issue":"11","key":"844_CR29","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1158\/1055-9965.EPI-06-0436","volume":"15","author":"T Nakajima","year":"2006","unstructured":"Nakajima T, Maekita T, Oda I, Gotoda T, Yamamoto S, Umemura S, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Prev Biomark. 2006;15(11):2317\u201321.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"4","key":"844_CR30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/1055-9965.EPI-07-2762","volume":"17","author":"K Yanaoka","year":"2008","unstructured":"Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, et al. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomark Prev. 2008;17(4):838\u201345.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"10","key":"844_CR31","doi-asserted-by":"publisher","first-page":"e109783","DOI":"10.1371\/journal.pone.0109783","volume":"9","author":"T Terasawa","year":"2014","unstructured":"Terasawa T, Nishida H, Kato K, Miyashiro I, Yoshikawa T, Takaku R, et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. PLoS One. 2014;9(10):e109783.","journal-title":"PLoS One"},{"issue":"2","key":"844_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.15430\/JCP.2013.18.2.107","volume":"18","author":"S Lee","year":"2013","unstructured":"Lee S, Park JM, Park SH, Kim EH, Hahm KB. The Korean perspective of Helicobacter pylori infection: lessons from Japan policy to prevent gastric cancer. J Cancer Prev. 2013;18(2):107\u201312.","journal-title":"J Cancer Prev"},{"issue":"8","key":"844_CR33","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2217\/fon.14.29","volume":"10","author":"Y Yamaoka","year":"2014","unstructured":"Yamaoka Y, Graham DY. Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014;10(8):1487\u2013500.","journal-title":"Future Oncol"},{"issue":"27","key":"844_CR34","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.3748\/wjg.v21.i27.8408","volume":"21","author":"T Matsuhisa","year":"2015","unstructured":"Matsuhisa T, Yamaoka Y, Uchida T, Duger D, Adiyasuren B, Khasag O, et al. Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection. World J Gastroenterol. 2015;21(27):8408\u201317.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"844_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jcmgh.2017.01.004","volume":"3","author":"JL Merchant","year":"2017","unstructured":"Merchant JL, Ding L. Hedgehog signaling links chronic inflammation to gastric cancer precursor lesions. Cell Mol Gastroenterol Hepatol. 2017;3(2):201.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"844_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s10620-012-2360-8","volume":"58","author":"T Uehara","year":"2013","unstructured":"Uehara T, Ma D, Yao Y, Lynch JP, Morales K, Ziober A, et al. H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig Dis Sci. 2013;58(1):140\u20139.","journal-title":"Dig Dis Sci"},{"key":"844_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2014\/481607","volume":"2014","author":"S Massarrat","year":"2014","unstructured":"Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Aliasgari A, Rakhshani N, et al. Pepsinogen II can be a potential surrogate marker of morphological changes in corpus before and after H. pylori eradication. BioMed Res Int. 2014;2014:7.","journal-title":"BioMed Res Int"},{"issue":"3","key":"844_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000081517","volume":"70","author":"F Di Mario","year":"2004","unstructured":"Di Mario F, Moussa AM, Cavallaro LG, Caruana P, Merli R, Bertolini S, et al. Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection. Digestion. 2004;70(3):167\u201372.","journal-title":"Digestion"},{"issue":"11","key":"844_CR39","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1440-1746.2007.04983.x","volume":"23","author":"SI Pimanov","year":"2008","unstructured":"Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. J Gastroenterol Hepatol. 2008;23(11):1666\u201371.","journal-title":"J Gastroenterol Hepatol"},{"issue":"48","key":"844_CR40","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.3748\/wjg.v18.i48.7357","volume":"18","author":"X-Y Cao","year":"2012","unstructured":"Cao X-Y, Jia Z-F, Jin M-S, Cao D-H, Kong F, Suo J, et al. Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol. 2012;18(48):7357.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"844_CR41","first-page":"261","volume":"7","author":"M Inoue","year":"1998","unstructured":"Inoue M, Kobayashi S, Matsuura A, Hamajima N, Tajima K, Tominaga S. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidemiol Prev Biomark. 1998;7(3):261\u20133.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"7","key":"844_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cgh.2017.01.006","volume":"15","author":"S Shiota","year":"2017","unstructured":"Shiota S, Thrift AP, Green L, Shah R, Verstovsek G, Rugge M, Graham DY, El-Serag HB. Clinical manifestations of helicobacter pylori\u2013negative gastritis. Clin Gastroenterol Hepatol. 2017;15(7):1037\u201346.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"844_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2011.12.004","volume":"21","author":"M Quante","year":"2012","unstructured":"Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell. 2012;21(1):36\u201351.","journal-title":"Cancer Cell"},{"issue":"4","key":"844_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4251\/wjgo.v8.i4.341","volume":"8","author":"SF Zaidi","year":"2016","unstructured":"Zaidi SF. Helicobacter pylori associated Asian enigma: does diet deserve distinction? World J Gastrointest Oncol. 2016;8(4):341.","journal-title":"World J Gastrointest Oncol"},{"key":"844_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/978-1-61779-612-8_26","volume":"863","author":"J Zabaleta","year":"2012","unstructured":"Zabaleta J. Multifactorial etiology of gastric cancer. Cancer Epigenet Methods Protoc. 2012;863:411\u201335.","journal-title":"Cancer Epigenet Methods Protoc."},{"issue":"2","key":"844_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/030089160609200212","volume":"92","author":"M Vasavi","year":"2006","unstructured":"Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori. 2006;92(2):155\u201362.","journal-title":"Tumori"},{"issue":"1","key":"844_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.bjc.6601511","volume":"90","author":"S Tsugane","year":"2004","unstructured":"Tsugane S, Sasazuki S, Kobayashi M, Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer. 2004;90(1):128.","journal-title":"Br J Cancer"},{"issue":"7","key":"844_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1158\/1055-9965.EPI-16-1024","volume":"26","author":"JH Song","year":"2017","unstructured":"Song JH, Kim YS, Heo NJ, Lim JH, Yang SY, Chung GE, Kim JS. High salt intake is associated with atrophic gastritis with intestinal metaplasia. Cancer Epidemiology and Prevention Biomarkers. 2017;26(7):1133\u20138.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"5","key":"844_CR49","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/1055-9965.EPI-05-0860","volume":"15","author":"A Kubo","year":"2006","unstructured":"Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Prev Biomark. 2006;15(5):872\u20138.","journal-title":"Cancer Epidemiol Prev Biomark"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-018-0844-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-018-0844-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-018-0844-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T09:31:41Z","timestamp":1589448701000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-018-0844-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1007\/s10120-018-0844-8","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standard of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Ethical approval was obtained from the Ethics Committees of Ministry of Health, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia and Oita University Faculty of Medicine, Japan. Informed consents were obtained from all patients for their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights statement and informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}